Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Cabotegravir is not associated with weight gain in human immunodeficiency virus-uninfected individuals in HPTN 077

Clinical Infectious Diseases, Volume 70, No. 2, Year 2020

Studies in human immunodeficiency virus (HIV)-infected individuals suggest excess weight gain with integrase inhibitor- based antiretroviral therapy. The HIV Prevention Trials Network Study 077 evaluated changes in weight and fasting metabolic parameters in HIV-uninfected individuals randomized to cabotegravir or a placebo. No differences between arms were found for change in weight or fasting metabolic parameters overall or for subgroups.
Statistics
Citations: 27
Authors: 18
Affiliations: 11
Identifiers
Research Areas
Infectious Diseases
Noncommunicable Diseases